Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Toucan Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 6
Rounds per year 0.45
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 2
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Renewable Energy
  • Advanced Materials
  • Energy
  • Nanotechnology
Summary

Toucan Capital is the famous VC, which was founded in 2001. The main department of described VC is located in the Bethesda. The fund was located in North America if to be more exact in United States.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Intrapace, Pepgen Corporation, Q Therapeutics Among the most popular fund investment industries, there are Medical, Clinical Trials.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Toucan Capital, startups are often financed by Silicon Alley Venture Partners, Sevin Rosen Funds, Next47. The meaningful sponsors for the fund in investment in the same round are Silicon Alley Venture Partners, Sevin Rosen Funds, Next47. In the next rounds fund is usually obtained by Sevin Rosen Funds, Silicon Alley Venture Partners, Next47.

The fund is generally included in less than 2 deals every year. Comparing to the other companies, this Toucan Capital performs on 15 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top amount of exits for fund were in 2009. Considering the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2004.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ashwin LLC -
Associated Bank Green Bay, United States, Wisconsin
Cars.com Chicago, Illinois, United States
China Mobile Innovation Industry Fund Beijing, Beijing, China
Digital Hollywood Japan, Tokyo
Drobny Global Advisors California, Manhattan Beach, United States
F50 Austin, Texas, United States
FIDURA Capital Consult Bayern, Germany, München
Force Ventures Berlin, Berlin, Germany
Greater Manchester Cyber Foundry -
Oriental Bank Of Commerce Gurgaon, Haryana, India
Orion Resource Partners New York, New York, United States
Purple Arch Ventures Chicago, Illinois, United States
RAIN Source Capital Minneapolis, Minnesota, United States
Reservoir Investment Managers Bangalore, India, Karnataka
Sidecar Fund2 -
The Phoenix Partners Seattle, United States, Washington
Veritech Ventures New York, New York, United States
Wyndcrest Partners -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

INmuneBIO

Biotechnology
Commercial
Industrial
Medical
$7M10 Jun 2019 San Diego, California, United States

Reactive NanoTechnologies

Advanced Materials
Energy
Manufacturing
Nanotechnology
Renewable Energy
$4M02 May 2008 Maryland, United States

Q Therapeutics

Biotechnology
Health Care
Therapeutics
$15M15 Feb 2008 Salt Lake City, Utah, United States

Reactive NanoTechnologies

Advanced Materials
Energy
Manufacturing
Nanotechnology
Renewable Energy
$6M07 Jan 2008 Maryland, United States

Pepgen

Biopharma
Medical
Pharmaceutical
$7M03 Aug 2004 Alameda, California, United States

Intrapace

Biotechnology
Health Care
Health Diagnostics
$14M14 Jul 2004 San Jose, California, United States

Reactive NanoTechnologies

Advanced Materials
Energy
Manufacturing
Nanotechnology
Renewable Energy
$8M05 Mar 2004 Maryland, United States

Reactive NanoTechnologies

Advanced Materials
Energy
Manufacturing
Nanotechnology
Renewable Energy
$1M03 Jan 2003 Maryland, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Toucan Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: